ENTITY
Grifols

Grifols (GRFS US)

19
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullishGrifols SA
20 Nov 2024 16:18

Lowball Non-Binding Indication from Brookfield

Rejected Offer: Grifols' independent committee rejected Brookfield's proposed valuation of €10.50 per Class A share, citing significant...

Share
bullishGrifols SA
18 Nov 2024 22:21

Liquid Universe of European Ordinary and Preferred Shares: November‘24 Report

Since mid-October, share-price spreads have generally tightened across European liquid universe of ordinary and preferred shares (10 have...

Share
bullishGalaxy Gaming
18 Nov 2024 11:53

SSI Weekly: Galaxy Gaming Acquisition and Other Portfolio Updates

Galaxy Gaming is being acquired by Evolution AB for $3.20/share, with a 17% spread and minimal regulatory hurdles. Other updates follow.

Share
04 Nov 2024 09:00

SSI Weekly Newsletter: October Performance, Portfolio Updates, and Key Developments

SSI Tracking Portfolio decreased by 3.1% in October but is up 6.6% year-to-date, with detailed stock performance breakdown available.

04 Nov 2024 09:00

Active Merger Arbitrage and Litigation Opportunities: Key Insights on Current Financial Market

Learning Technologies Group and TI Fluid Systems are engaged in merger arbitrage, with due diligence and PUSU deadlines approaching.

x